A clinical trial to study the effects tyrosine nutraceutical bar (CognoBar) on cognitive function in stressful environment

Phase 2

• Registration Number: CTRI/2022/11/046969
• Lead Sponsor: Defence Institute of Physiology and Allied Sciences Defence Research and Development Organization

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Medical History:SHAPE-I

Weight:65±2 Kg

Exclusion Criteria

Free from any neurological disorder and cardiac problems and would not be taking any sort of psychotropic, psychoactive or any other medication during the course of the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Effect of CognoBar (Tyrosine nutraceutical bar) on Cognitive function at High Altitude (11000 to 12000 feet)Timepoint: 8-10 week after High altitude induction

Secondary Outcome Measures

Name	Time	Method
Effect of CognoBar (Tyrosine nutraceutical bar) on Cognitive function at Very High Altitude (13000 to 14000 feet)Timepoint: 8-10 week after Very High altitude induction